Antibiotic levels in breast milk under the microscope
NCT ID NCT07645235
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measures how much of the antibiotic gepotidacin passes into breast milk after a single 3000 mg dose. Eight healthy lactating women will provide milk and blood samples over 72 hours. The goal is to understand drug exposure for nursing infants, which could guide future use in breastfeeding mothers with urinary tract infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- gepotidacin
- What this could lead to
- If successful, this study could help determine whether gepotidacin is safe to use in breastfeeding women with urinary tract infections.
- What could go wrong
- This is a very small, early-phase study in healthy women, not patients. It only looks at drug levels, not safety or effectiveness in treating infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better school toilets and peer support boost girls' health and grades? a madagascar trial aims to find out.
- Can antibiotic wash and suction stop Post-Surgery infections?
- Gut bacteria transplant shows promise for recurring UTIs
- Simple bathroom habit may cut infection risk after kidney transplant
- Antibiotics before kidney drainage: help or hype?
- Stanford study on Kids' bathroom habits pulled before it began